Search

2 Aug 2010: www.landesbioscience.com Autophagy 805. Autophagy 6:6, 805-807; August 16, 2010; 2010 Landes BioscienceAUTOPHAGIC PUNCTUM AUTOPHAGIC PUNCTUM. Key words: Vps34, PI 3-kinase, struc-ture, inhibitor, enzyme, autophagy, Vps15, PtdIns3P, phosphoinositide.

6 Jun 2000: "# $. %! & ' () & ,! & ,! " # $ % # & # ' # & & & & # '! - - - -. ,! / 0012+ 3! )! , , 4! , / 005 002+ 3! /62! 3! 78& & &78& & /9) 00%2+ 3! &! & ' /! 82 - /! 8%2+ 8 &! : ,)! )! 78! &! & 3! )! & 4 ; & 9 /2 ,)! & 6 )! )! & /9) 00%2+ ) )! < /= 00>2+.

20 Apr 2002: Calcium-dependent Membrane Penetration Is a Hallmark of theC2 Domain of Cytosolic Phospholipase A2 Whereas the C2A Domainof Synaptotagmin Binds Membranes Electrostatically. (Received for publication, May 21, 1998). Bazbek Davletov‡, Olga Perisic,

6 Oct 2004: Current Biology, Vol. 14, 1380–1384, August 10, 2004, 2004 Elsevier Ltd. All rights reserved. DOI 10.1016/j. c u b. 2 0 0 4. 0 7. 0 5 8. ARAP3 Is a PI3K- and Rap-Regulated GAP for RhoA. Further titration of the relative levels of ARAP3 andSonja

18 Dec 2008: DOI: 10.1126/science.1165322 , 1710 (2008); 322Science. et al.Rachel Y. Samson,ArchaeaA Role for the ESCRT System in Cell Division in. www.sciencemag.org (this information is current as of December 18, 2008 ):The following resources related to this

8 Dec 2007: DOI: 10.1126/science.1135394 , 239 (2007); 317Science. et al.Nabil Miled,the Phosphoinositide 3-Kinase Catalytic SubunitMechanism of Two Classes of Cancer Mutations in. www.sciencemag.org (this information is current as of December 8, 2007 ):The

20 Apr 2002: Proc. Natl. Acad. Sci. USAVol. 94, pp. 9637–9642, September 1997Biophysics. The 2.0-Å resolution crystal structure of a trimeric antibodyfragment with noncognate VH–VL domain pairs shows arearrangement of VH CDR3XUE Y. PEI, PHILIPP HOLLIGER,

2 Aug 2010: DOI: 10.1126/science.1184429 , 1638 (2010); 327Science. et al.Simon Miller,the Structure of the Lipid Kinase Vps34Shaping Development of Autophagy Inhibitors with. This copy is for your personal, non-commercial use only. clicking herecolleagues,

11 Jun 1997: Phosphoinositide-specific phospholipase C: structural basisfor catalysis and regulatory interactionsMatilda Katan and Roger L. Williams. Phosphoinositide-specific phospholipase C (PI-PLC) isozymeshave an important role in cellular responses to a

14 Jun 2007: 25. Structural studies of phosphoinositide 3-kinase-dependent traffi c to multivesicular bodiesDavid J. Gill1, Hsiangling Teo1, Ji Sun‡, Olga Perisic, Dmitry B. Veprintsev†, Yvonne Vallis, Scott D. Emr‡ and Roger L. Williams2. MRC Laboratory

8 Dec 2007: LETTERS. Structural basis for selective recognition of ESCRT-IIIby the AAA ATPase Vps4Takayuki Obita1, Suraj Saksena2, Sara Ghazi-Tabatabai1, David J. Gill1, Olga Perisic1, Scott D. Emr2. & Roger L. Williams1. The AAA1 ATPases are essential for

6 May 1999: Article No. jmbi.1999.2720 available online at http://www.idealibrary.com on J. Mol. Biol. (1999) 288, 649657. Crystal Structure of the Two N-terminal Domains ofg3p from Filamentous Phage fd at 1.9 AÊ : Evidence forConformational Lability. Philipp

25 Nov 2012: Oncogenic mutations mimic and enhance dynamicevents in the natural activation of phosphoinositide3-kinase p110α (PIK3CA)John E. Burke, Olga Perisic, Glenn R. Masson, Oscar Vadas, and Roger L. Williams1. Laboratory of Molecular Biology, Medical

20 Apr 2002: Review. Mammalian phosphoinositide-speci¢c phospholipase C. Roger L. Williams Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK. Received 1 April 1999 ; received in revised form 17 June 1999 ; accepted 31

20 Apr 2002: Crystal Structure of a Calcium-Phospholipid Binding Domainfrom Cytosolic Phospholipase A2. (Received for publication, September 24, 1997). Olga Perisic‡, Sun Fong, Denise E. Lynch‡, Mark Bycroft, and Roger L. Williams‡. From the ‡Medical

12 Nov 2006: Phosphoinositide 3-kinases as drug targets in cancerLen Stephens1, Roger Williams2 and Phillip Hawkins1. The past two years have seen phosphoinositide 3-kinases. (PI3Ks) move from being seen as potential targets for. chemotherapeutics, to one of

21 Nov 2012: ESCRT-III binding protein MITD1 is involved incytokinesis and has an unanticipated PLD foldthat binds membranesMichael A. Haddersa,1, Monica Agromayorb,2,1, Takayuki Obitaa,3, Olga Perisica, Anna Caballeb, Magdalena Klocb,Meindert H. Lamersa, Roger

24 Sep 2004: Structural Insights into Endosomal Sorting Complex Required forTransport (ESCRT-I) Recognition of Ubiquitinated Proteins. Received for publication, January 5, 2004, and in revised form, March 22, 2004Published, JBC Papers in Press, March 24, 2004,

11 Nov 1999: 1999 Macmillan Magazines Ltd. letters to nature. NATURE | VOL 402 | 18 NOVEMBER 1999 | www.nature.com 313. 12. Macleod, K. F. et al. p53-dependent and independent expression of p21 during cell growth,. differentiation, and DNA damage. Genes Dev. 9,

20 Apr 2002: Mapping the Phospholipid-binding Surface and TranslocationDeterminants of the C2 Domain from Cytosolic Phospholipase A2. (Received for publication, November 9, 1998, and in revised form, January 14, 1999). Olga Perisic‡, Hugh F. Paterson, Georgina